<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cell Biol</journal-id><journal-title>BMC Cell Biology</journal-title><issn pub-type="epub">1471-2121</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2121-5-38</article-id><article-id pub-id-type="pmid">15488148</article-id><article-id pub-id-type="doi">10.1186/1471-2121-5-38</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Two <italic>Drosophila </italic>suppressors of cytokine signaling (SOCS) differentially regulate JAK and EGFR pathway activities</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Rawlings</surname><given-names>Jason S</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jrawling@uky.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Rennebeck</surname><given-names>Gabriela</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>grenne2@uky.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Harrison</surname><given-names>Susan MW</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>swharri@uky.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Xi</surname><given-names>Rongwen</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rox@Stowers-Institute.org</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Harrison</surname><given-names>Douglas A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dough@email.uky.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Dept. of Biology, University of Kentucky, 101 Morgan Bldg. Lexington, KY, 40506, USA</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>15</day><month>10</month><year>2004</year></pub-date><volume>5</volume><fpage>38</fpage><lpage>38</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2121/5/38"/><history><date date-type="received"><day>1</day><month>6</month><year>2004</year></date><date date-type="accepted"><day>15</day><month>10</month><year>2004</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2004 Rawlings et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder>Rawlings et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Rawlings S Jason jrawling@uky.edu </dc:author><dc:title> Two Drosophila suppressors of cytokine signaling (SOCS) differentially regulate JAK and EGFR pathway activities </dc:title><dc:date>2004</dc:date><dcterms:bibliographicCitation>BMC Cell Biology 5(1): 38-. (2004)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2121(2004)5:1&#x0003c;38&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2121</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The Janus kinase (JAK) cascade is an essential and well-conserved pathway required to transduce signals for a variety of ligands in both vertebrates and invertebrates. While activation of the pathway is essential to many processes, mutations from mammals and <italic>Drosophila </italic>demonstrate that regulation is also critical. The SOCS (<underline>S</underline>uppressor <underline>O</underline>f <underline>C</underline>ytokine <underline>S</underline>ignaling) proteins in mammals are regulators of the JAK pathway that participate in a negative feedback loop, as they are transcriptionally activated by JAK signaling. Examination of one <italic>Drosophila </italic>SOCS homologue, Socs36E, demonstrated that its expression is responsive to JAK pathway activity and it is capable of downregulating JAK signaling, similar to the well characterized mammalian SOCS.</p></sec><sec><title>Results</title><p>Based on sequence analysis of the <italic>Drosophila </italic>genome, there are three identifiable SOCS homologues in flies. All three are most similar to mammalian SOCS that have not been extensively characterized: Socs36E is most similar to mammalian SOCS5, while Socs44A and Socs16D are most similar to mammalian SOCS6 and 7. Although Socs44A is capable of repressing JAK activity in some tissues, its expression is not regulated by the pathway. Furthermore, Socs44A can enhance the activity of the EGFR/MAPK signaling cascade, in contrast to Socs36E.</p></sec><sec><title>Conclusions</title><p>Two <italic>Drosophila </italic>SOCS proteins have some overlapping and some distinct capabilities. While Socs36E behaves similarly to the canonical vertebrate SOCS, Socs44A is not part of a JAK pathway negative feedback loop. Nonetheless, both SOCS regulate JAK and EGFR signaling pathways, albeit differently. The non-canonical properties of Socs44A may be representative of the class of less characterized vertebrate SOCS with which it shares greatest similarity.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The vertebrate JAK signaling pathway is an essential component of cellular response to a wide array of cytokines and growth factors. The JAK cascade is reutilized for signaling events in numerous tissues and at multiple stages of mammalian development [reviewed by [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]]. Many interleukins, interferons, and growth factors are among the ligands that stimulate signaling through the JAK pathway. The pathway can also be stimulated through activation of some receptor tyrosine kinases, including epidermal growth factor receptor (EGFR). As a result of its broad utilization, JAK signaling is essential for many developmental events.</p><p>Though the JAK pathway is vital to many developmental processes, strict control of JAK signaling is equally important. As with other signaling pathways, mechanisms must be in place to balance the activation of JAK pathway activity. Regulation serves to "reset" the pathway so that it will be responsive to subsequent signals and it restricts the level or duration of the signal so that it is properly interpreted by the cell. Inappropriate JAK activation is the direct cause of a specific form of acute lymphocytic leukemia (ALL) [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. In addition, JAK/STAT activation has been strongly correlated with a variety of cancers, including many blood cell and immune cell transformations [reviewed by [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref>]]. Furthermore, in cell culture, constitutive activation of c-Eyk, v-src, or v-abl results in the constitutive activation of specific STATs or JAKs [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. These examples highlight the necessity of regulating JAK/STAT activation.</p><p>Because of the need to limit JAK activity, it is not surprising that there are several conserved protein families that regulate JAK activation [reviewed by [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]]. These include phosphatases, Protein Inhibitors of Activated STATs (PIAS), and, the best characterized, the suppressors of cytokine signaling (SOCS) family. In mammals, eight different SOCS genes have been found [<xref ref-type="bibr" rid="B16">16</xref>]. These SOCS proteins have a distinctive modular architecture: a central SH2 domain followed by a carboxyl terminal SOCS domain, while the amino termini are quite divergent. Biochemical investigations have revealed that SOCS proteins use multiple mechanisms to regulate activity of the JAK pathway [see reviews, [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B9">9</xref>]]. First, the SOCS SH2 domain can bind to the phosphorylated receptor, thereby prohibiting access to positive effectors of the pathway. Second, at least some SOCS can specifically inhibit the catalytic activity of JAKs. Lastly, SOCS binding to activated JAK pathway components may target those proteins for degradation. The SOCS motif interacts with the elongins B and C, which bind to cullins and are E3 ubiquitin ligases [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. Addition of ubiquitin to the bound proteins would target them for proteasomal degradation. Therefore, the negative influence of SOCS on its substrates may be due to multiple distinct mechanisms.</p><p>Use of the JAK signaling pathway for developmental processes is not restricted to mammals. Indeed, the JAK cascade is evolutionarily conserved, and can be found as an intact signaling pathway even in insects [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B21">21</xref>]. In <italic>Drosophila</italic>, the JAK pathway is involved in embryonic patterning, sex determination, blood cell development, patterning of adult structures, planar polarity of photoreceptor clusters, maintenance of stem cells in spermatogenesis, and follicle cell patterning and function [see reviews [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B21">21</xref>]]. Furthermore, the fly JAK pathway must also be properly regulated to avoid deleterious effects. As in vertebrates, hyperactive JAK signaling has also been shown to directly cause neoplastic cell growth in <italic>Drosophila</italic>. Two dominant gain-of-function alleles of <italic>hopscotch </italic>result in hypertrophy of the larval lymph glands, the hematopoietic organ, and melanotic masses [<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. Excess activity in the blood system causes overproliferation and differentiation of the macrophage-like blood cells, creating leukemia-like effects. Inappropriate activity in the developing tissues of the adult fly can also cause alteration of the development of the adult thorax, wing veins, head, eyes, and ovaries [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>].</p><p>Of the eight mammalian SOCS, four have been studied extensively (CIS, SOCS1-3). These genes have been shown to respond to JAK pathway activation and subsequently are able to downregulate its activity as described above, completing a classical negative feedback loop. In comparison, very little is known of the remaining four. Here we present the identification and characterization of <italic>Drosophila </italic>Socs44A. It contains the same modular domain architecture as mammalian SOCS and shows greatest sequence similarity to the relatively uncharacterized SOCS6 and SOCS7. We show that, unlike the previously studied <italic>Drosophila Socs36E </italic>[<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>], <italic>Socs44A </italic>expression in embryogenesis is independent of JAK pathway activity. However, Socs44A is able to regulate the JAK cascade in embryogenesis, but not in oogenesis. Finally, <italic>Socs44A </italic>genetically interacts with and upregulates the EGFR/MAPK pathway. The characteristics of Socs44A that distinguish it from the canonical Socs36E may be representative of features that are shared with the class of less-defined mammalian SOCS genes.</p></sec><sec><title>Results</title><sec><title>The <italic>Drosophila </italic>genome encodes three putative SOCS genes</title><p>Based on the consensus protein sequence for a SOCS box derived by Hilton and colleagues [<xref ref-type="bibr" rid="B30">30</xref>], a tBLASTn search of the Berkeley <italic>Drosophila </italic>Genome Project (BDGP) database [<xref ref-type="bibr" rid="B31">31</xref>] was conducted to examine all possible reading frames. Three putative loci containing both a SOCS box and an SH2 domain were identified using this strategy. All three match the arrangement of mammalian SOCS genes in that the SOCS box is at the carboxyl terminus with the SH2 domain directly preceding it. Each of these putative homologues also overlaps with a predicted gene from the BDGP. We named these three genes <italic>Socs16D </italic>(overlapping with CG8146), <italic>Socs36E </italic>(overlapping with CG15154), and <italic>Socs44A </italic>(CG2160), based upon their cytological location. Comparison of these three fly SOCS genes with vertebrate SOCS reveals that Socs36E is most similar to the mouse SOCS5, while Socs16D and Socs44A are less similar to specific mouse SOCS (see Fig. <xref ref-type="fig" rid="F1">1</xref>). While the amino termini are quite different, SOCS5 and Socs36E are 62% identical (71% similar) at the carboxy terminus from the region just before the SH2 domain to the end of the SOCS domain (region shown in Fig. <xref ref-type="fig" rid="F1">1A</xref>). Within that same C-terminal region, Socs44A is most similar to SOCS6 and SOCS7 (46% and 39% similar, respectively). Socs16D also has highest similarity to SOCS6 and SOCS7 (47% to each) over the same carboxyl region. These similarities suggest that the ancestral versions of <italic>Socs36E </italic>and a common predecessor of <italic>Socs16D </italic>and <italic>Socs44A </italic>existed as two separate SOCS genes at the time of divergence of mammals and dipterans (Fig. <xref ref-type="fig" rid="F1">1B</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Protein sequence comparison of <italic>Drosophila </italic>and mouse SOCS. </bold>(A) The predicted carboxyl terminal protein sequences of <italic>Drosophila </italic>(d), mouse (m), and <italic>C. elegans </italic>(ce) SOCS genes, including the SH2 and SOCS box domains, are aligned and shaded to indicate similarities and identities. (B) Based on the protein alignments, the neighbor-joining method was used to construct a phylogenetic tree of these SOCS.</p></caption><graphic xlink:href="1471-2121-5-38-1"/></fig></sec><sec><title>Socs44A expression is not regulated by JAK pathway activity</title><p>In mammals, regulation of JAK signaling through SOCS proteins is based on a simple negative feedback mechanism. Specifically, the activity of the JAK pathway stimulates the expression of SOCS genes, because activated STATs bind to enhancers for the SOCS genes and induce transcription. <italic>Socs36E </italic>is similarly regulated during embryogenesis by <italic>Drosophila </italic>JAK signaling [<xref ref-type="bibr" rid="B29">29</xref>]. <italic>Socs36E </italic>is expressed dynamically, in a striped pattern that later becomes restricted predominantly to the tracheal pits [[<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>], and Fig. <xref ref-type="fig" rid="F3">3</xref>], very similar to <italic>upd</italic>, the gene encoding the embryonic ligand for the JAK pathway [<xref ref-type="bibr" rid="B32">32</xref>]. Indeed, activation of JAK signaling is both necessary and sufficient for <italic>Socs36E </italic>expression in embryogenesis [<xref ref-type="bibr" rid="B29">29</xref>]. Furthermore, the expression of Socs36E during oogenesis matches the known activation of JAK signaling. The expression of <italic>upd </italic>in the ovaries is restricted to the two polar follicle cells at either end of the egg chambers of the vitellarium [[<xref ref-type="bibr" rid="B26">26</xref>] and Fig. <xref ref-type="fig" rid="F2">2C</xref>]. <italic>Socs36E </italic>is expressed in a larger number of follicle cells centered at the two poles of the egg chamber (Fig. <xref ref-type="fig" rid="F2">2D</xref>). Given that secreted Upd protein is produced in the polar follicle cells and activates JAK signaling in neighboring cells [<xref ref-type="bibr" rid="B33">33</xref>], this suggests that <italic>Socs36E </italic>expression is controlled by JAK activity in oogenesis, as well as embryogenesis.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Loss of JAK activity does not affect <italic>Socs44A </italic>expression. </bold>As compared with wild-type at various embryonic stages (A and B), germline clone derived embryos from <italic>hop</italic><sup><italic>c111 </italic></sup>mothers (C-H) display dramatically reduced or eliminated expression of <italic>Socs36E </italic>(C and D). Only a stripe of mesodermal staining in germ band extended embryos (D) remains at nearly normal intensity in the mutant embryos. In contrast, expression of <italic>Socs44A </italic>in trachea persists in <italic>hop</italic><sup><italic>c111 </italic></sup>germline clone-derived embryos that are unrescued (E) or paternally rescued (F). However, the trachea are morphologically altered and drastically reduced in unrescued (G) and paternally rescued (H) animals, as compared with wild-type (I), as evidenced by a <italic>trachealess </italic>enhancer trap (G-I).</p></caption><graphic xlink:href="1471-2121-5-38-3"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold><italic>Socs36E </italic>and <italic>Socs44A </italic>are expressed in different spatio-temporal patterns. </bold>The embryonic expression patterns of <italic>upd </italic>and <italic>Socs36E </italic>are dynamic from early blastoderm throughout embryogenesis [see 28, 29 and Fig. 3]. <italic>Socs44A </italic>expression is not detected until very late stages in the trachea (A). Although such staining can be artifactual, sense strand probe never showed any staining (B). In the ovary, <italic>upd </italic>is expressed specifically in the polar follicle cells at each end of the chamber (C). <italic>Socs36E </italic>expression encompasses the anterior and posterior follicular epithelium, with highest expression at the poles (D). This is consistent with activation of <italic>Socs36E </italic>transcription due to reception of the Upd ligand which is secreted from the polar follicle cells and diffuses toward surrounding cells. <italic>Socs44A </italic>expression is restricted to the germline and only during later stages of oogenesis (E)</p></caption><graphic xlink:href="1471-2121-5-38-2"/></fig><p>The <italic>Socs44A </italic>gene that was predicted based on protein homology is identical to hypothetical gene CG2160. A single cDNA corresponding to the locus (LP02169) was isolated by the BDGP, has been completely sequenced and encodes the expected SH2 and SOCS domains at the carboxyl terminus (gb AF435923). To determine whether <italic>Socs44A </italic>is similarly regulated by JAK pathway activity, in situ hybridization to embryos and ovaries was performed. No specific expression of <italic>Socs44A </italic>was detected until very late in embryogenesis. The only striking staining pattern observed was in the trachea of late embryos (Fig. <xref ref-type="fig" rid="F2">2A</xref>). Non-specific tracheal staining is sometimes seen with probes to late embryos, however this pattern was never observed when sense probe was used (Fig. <xref ref-type="fig" rid="F2">2B</xref>). Unfortunately, embryos homozygous for any available deletions that remove Socs44A die prior to formation of trachea, therefore we cannot conclusively determine whether the late tracheal staining reflects RNA expression. Nonetheless, because the JAK pathway is activated in a segmentally repeated pattern during embryogenesis, the lack of <italic>Socs44A </italic>expression suggests that it is not responsive to JAK signaling. Consistent with this conclusion, expression of <italic>Socs44A </italic>in the ovary is restricted to only germline expression late in oogenesis, with no detectable RNA in the follicular epithelium (Fig. <xref ref-type="fig" rid="F2">2E</xref>).</p><p>To directly test whether <italic>Socs44A </italic>expression is regulated by JAK pathway activity, in situ hybridization to <italic>Socs44A </italic>RNA was performed in embryos that lack JAK pathway activity. The product of the <italic>hop </italic>gene is required in early embryogenesis and must be provided maternally for proper segmentation of the embryo. The dominant female sterile (DFS) technique was used to generate females that fail to produce <italic>hop </italic>in the germline [<xref ref-type="bibr" rid="B34">34</xref>]. In situ hybridization of <italic>hop </italic>germline clone embryos using <italic>Socs36E </italic>as probe demonstrates a strong reduction in <italic>Socs36E </italic>expression in the mutant embryos as compared with wild-type (Fig. <xref ref-type="fig" rid="F3">3</xref>). Similar results have been reported in embryos lacking <italic>upd </italic>activity [<xref ref-type="bibr" rid="B29">29</xref>]. These data demonstrate that <italic>hop </italic>is required to stimulate the normal segmentally-repeated <italic>Socs36E </italic>expression in the embryo. However, expression of <italic>Socs44A </italic>does not appear to be affected by maternal loss of <italic>hop</italic>. Although the trachea are malformed and dramatically reduced in embryos lacking JAK pathway activity [[<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>] and Fig. <xref ref-type="fig" rid="F3">3G,3H</xref>], the remaining segments of trachea continue to express <italic>Socs44A </italic>at apparently normal levels (Fig. <xref ref-type="fig" rid="F3">3E,3F</xref>). Thus the failure of endogenous <italic>Socs44A </italic>to be expressed in the normal pattern of JAK pathway activation and of <italic>Socs44A </italic>expression to be eliminated by loss of JAK activity indicate that <italic>Socs44A </italic>expression is not stimulated by the pathway.</p><p>Activity of the JAK pathway is both necessary and sufficient for the expression of <italic>Socs36E</italic>. The ectopic activation of the JAK pathway by misexpression of <italic>upd </italic>results in expression of <italic>Socs36E </italic>in the same pattern [[<xref ref-type="bibr" rid="B29">29</xref>] and data not shown]. In contrast, similar misexpression of UAS-upd with the paired-GAL4 driver failed to stimulate any detectable expression of <italic>Socs44A </italic>in the embryo (not shown). We conclude that <italic>Socs44A </italic>expression is not responsive to JAK pathway activity, therefore cannot function via a traditional auto-regulatory feedback loop.</p></sec><sec><title>Ectopic SOCS activity suppresses JAK signaling in the wing</title><p>The lack of transcriptional regulation by JAK signaling does not preclude a role for Socs44A in the control of JAK activity. To test whether it can attenuate JAK signaling, <italic>Socs44A </italic>was misexpressed using the GAL4/UAS system. Similar experiments performed with <italic>Socs36E </italic>have demonstrated that expression in the developing wing reproducibly results in the production of ectopic wing vein near the posterior crossvein [Fig. <xref ref-type="fig" rid="F4">4C</xref> and [<xref ref-type="bibr" rid="B28">28</xref>]]. This phenotype is quite similar to that noted for viable mutants of <italic>hop </italic>or <italic>Stat92E </italic>[Fig. <xref ref-type="fig" rid="F4">4B</xref> and [<xref ref-type="bibr" rid="B37">37</xref>]], suggesting that <italic>Socs36E </italic>misexpression may cause a reduction in JAK signaling in the wing. But unlike observed JAK mutations, the anterior crossvein was also completely missing from <italic>Socs36E </italic>misexpression wings, perhaps suggesting an additional role for Socs36E that is independent of the JAK pathway. Callus and Mathey-Prevot [<xref ref-type="bibr" rid="B28">28</xref>] demonstrated that the additional influence on wing venation may be due to the suppression of the EGFR pathway.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold><italic>Socs44A </italic>misexpression reduces JAK signaling in the wing. </bold>Wild-type venation (A) is compared with a viable <italic>hop </italic>mutant, <italic>hop</italic><sup><italic>msv</italic></sup>/<italic>hop</italic><sup><italic>M38 </italic></sup>(B). <italic>hop </italic>reduction causes ectopic vein (arrow) near the posterior crossvein. (C) Expression of UAS-Socs36E using the engrailed-GAL4 driver (e16E-GAL) produces a similar ectopic vein phenotype, plus the loss of the anterior crossvein (arrowhead). (D) Similar misexpression of <italic>Socs44A </italic>causes ectopic wing vein production near the posterior crossvein (arrow) and arching of vein L3 (arrowhead). (E) Reduction of the dosage of <italic>hop </italic>enhances the <italic>Socs44A </italic>misexpression phenotype. (F) Misexpression of <italic>hop </italic>in the posterior compartment causes dramatic vein loss, but that loss is restored by the simultaneous expression of <italic>Socs44A </italic>(G).</p></caption><graphic xlink:href="1471-2121-5-38-4"/></fig><p>Using the engrailed-GAL driver, GAL-e16E, expression of <italic>Socs44A </italic>in the posterior compartment of the wing caused mild venation defects similar, but not identical, to <italic>Socs36E </italic>(Fig. <xref ref-type="fig" rid="F4">4D</xref>). Expression of <italic>Socs44A </italic>caused production of ectopic wing vein near the posterior crossvein, but unlike <italic>Socs36E</italic>, the ectopic vein was seen predominantly posterior to L5, not between L4 and L5. Furthermore, the anterior crossvein was not reduced or eliminated by <italic>Socs44A </italic>expression, but a substantial arching of L3 was noticed. Both the ectopic vein and arching of L3 were enhanced in animals heterozygous for a null allele of <italic>hop </italic>(Fig. <xref ref-type="fig" rid="F4">4E</xref>), indicating that the phenotype is sensitive to a reduction in JAK pathway activity. Misexpression of <italic>hop </italic>activates JAK signaling and causes reduction of wing venation in the posterior of the wing, somewhat the opposite of <italic>Socs44A </italic>misexpression (Fig. <xref ref-type="fig" rid="F4">4F</xref>). The simultaneous misexpression of <italic>hop </italic>and <italic>Socs44A </italic>results in a phenotype similar to expression of <italic>Socs44A </italic>alone (Fig. <xref ref-type="fig" rid="F4">4G</xref>). Therefore, the activity of Socs44A is capable of negating the influence of ectopic JAK activity in the wing.</p><p>Loss of JAK function in embryos is lethal, but various combinations of weak alleles of <italic>hop </italic>show some viability (Table <xref ref-type="table" rid="T1">1</xref>). If Socs44A were negatively regulating the JAK pathway, misexpression of <italic>Socs44A </italic>in a <italic>hop </italic>mutant background would be expected to further reduce viability. The ability of <italic>Socs44A </italic>misexpression to enhance the lethality of weak heteroallelic combinations of <italic>hop </italic>was tested. For all alleles examined, expression of <italic>Socs44A </italic>in the <italic>engrailed </italic>pattern caused complete lethality. For the weakest <italic>hop </italic>allelic combination, <italic>hop</italic><sup><italic>msv</italic></sup>/<italic>hop</italic><sup><italic>M75</italic></sup>, misexpression of <italic>Socs44A </italic>caused viability to drop from 62% to 0% (Table <xref ref-type="table" rid="T1">1</xref>). These data are consistent with the hypothesis that ectopic <italic>Socs44A </italic>acts to further reduce pathway activity in these JAK activity depleted animals, causing lethality.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Misexpression of Socs44A exacerbates the reduced viability of <italic>hop </italic>heteroallic mutants.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Genotype</bold></td><td align="center"><bold>hop<sup>M38 </sup>(n = 213)</bold></td><td align="center"><bold>hop<sup>GA32 </sup>(n = 332)</bold></td><td align="center"><bold>hop<sup>M75 </sup>(n = 172)</bold></td></tr></thead><tbody><tr><td align="left"><bold>A</bold>- hop<sup>x</sup>/FM7; en-GAL; TM3</td><td align="center">33</td><td align="center">52</td><td align="center">21</td></tr><tr><td align="left"><bold>B</bold>- hop<sup>x</sup>/FM7; en-GAL; UAS-socs44A</td><td align="center">25</td><td align="center">33</td><td align="center">28</td></tr><tr><td align="left"><bold>C</bold>- hop<sup>x</sup>/hop<sup>msv</sup>; en-GAL; TM3</td><td align="center">11</td><td align="center">20</td><td align="center">13</td></tr><tr><td align="left"><bold>D</bold>- hop<sup>x</sup>/hop<sup>msv</sup>; en-GAL; UAS-socs44A</td><td align="center">0 (E = 8.33)</td><td align="center">0 (E = 12.69)</td><td align="center">0 (E = 17.33)</td></tr></tbody></table><table-wrap-foot><p>Misexpression of <italic>Socs44A </italic>in a range of <italic>hop </italic>heteroallelic mutants resulted in lethality. For each mutant combination, <bold>x </bold>is the allele of <italic>hop </italic>designated in the column heading, <bold>n </bold>represents the total number of progeny scored in the cross. <bold>E </bold>represents the expected number of progeny of that genotype if <italic>Socs44A </italic>misexpression were to have no effect on viability. The expected value is calculated using the formula <bold>A/B=C/D</bold>, which takes into account the change in viability imparted by homozygosity for <italic>hop </italic>relative to heterozygosity and the change in viability for misexpression of <italic>Socs44A </italic>relative to the GAL4 alone. The progeny scored here are derived from the cross: <italic>hop</italic><sup><italic>X</italic></sup>/<italic>Y Dp(1;Y)v</italic><sup>+</sup><italic>y</italic><sup>+</sup><italic>hop</italic><sup>+</sup>; <italic>en-GAL4/CyO </italic>males mated to <italic>hop</italic><sup><italic>msv</italic></sup>/<italic>FM7; UAS-socs44A/TM3 </italic>females.</p></table-wrap-foot></table-wrap><p>While the above data indicate that ectopic Socs44A is capable of downregulating JAK activity, they do not address whether Socs44A has an endogenous role in JAK pathway regulation. To determine if endogenous Socs44A downregulates JAK activity, we assayed the effect of a <italic>Socs44A </italic>deficiency on <italic>hop </italic>mutant phenotypes. The <italic>hop</italic><sup><italic>M38</italic>/<italic>msv </italic></sup>heteroallelic mutant exhibits wing vein material at the posterior crossvein (Fig <xref ref-type="fig" rid="F4">4B</xref>) that is 98% penetrant. Removal of a single copy of <italic>Socs44A </italic>using either of two deficiencies in the region reduced the penetrance of the <italic>hop </italic>phenotype by as much as 52% (Table <xref ref-type="table" rid="T2">2</xref>). An overlapping deficiency that did not remove the <italic>Socs44A </italic>locus had little effect on penetrance of the phenotype. These results suggest that regulation of JAK activity in the wing is a normal endogenous function of Socs44A.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Endogenous Socs44A regulates JAK pathway activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><bold>+/+</bold></td><td align="center"><bold>CA53/+ (n = 237)</bold></td><td align="center"><bold>NCX10/+ (n = 292)</bold></td><td align="center"><bold>Drl/+ (n = 242)</bold></td></tr></thead><tbody><tr><td align="center">hop<sup>M38</sup>/hop<sup>msv</sup></td><td align="center">98% (of 89)</td><td align="center">46% (of 13)</td><td align="center">58% (of 12)</td><td align="center">87% (of 15)</td></tr></tbody></table><table-wrap-foot><p><italic>hop</italic><sup><italic>msv</italic></sup>/<italic>hop</italic><sup><italic>M38 </italic></sup>heteroallelic females have a wing spur phenotype (Fig. 4B) that is 98% penetrant (n = 89). The penetrance of the spur phenotype is dramatically reduced by removal of one copy of <italic>Socs44A</italic>, as seen for heterozygotes of <italic>Df(2)CA53 </italic>(CA53)and <italic>Df(2)NCX10 </italic>(NCX10). Rescue of the phenotype was not seen with <italic>Df(2)Drl</italic><sup><italic>rv18 </italic></sup>(Drl), an overlapping deficiency that does not include <italic>Socs44A</italic>. Total number of animals is indicated by <bold>n</bold>, and number of animals of the indicated genotype is in parentheses.</p></table-wrap-foot></table-wrap></sec><sec><title>Socs44A upregulates EGFR pathway activity</title><p>In mammals, there are multiple points of cross-talk between the JAK and EGFR/MAPK signaling pathways [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B38">38</xref>-<xref ref-type="bibr" rid="B40">40</xref>]. EGFR signaling plays a prominent role in many developmental processes in <italic>Drosophila</italic>, including wing venation [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. As mentioned above, expression of <italic>Socs36E </italic>has been reported to suppress EGFR signaling in the wings [<xref ref-type="bibr" rid="B28">28</xref>]. To determine the relationship of Socs44A to EGFR/MAPK signaling, wing phenotypes due to misexpression of <italic>Socs44A </italic>were examined in the background of heterozygous mutations for components of the EGFR signaling pathway. <italic>Engrailed-GAL4 </italic>driven misexpression phenotypes of Socs44A were suppressed in the background of heterozygous mutations for <italic>Ras85D, Son of sevenless (Sos), </italic>and <italic>Egfr </italic>(Fig. <xref ref-type="fig" rid="F5">5A,5B,5C,5D</xref>). Consistent with these observations, reduction in the dosage of the EGFR negative regulator <italic>argos </italic>enhanced the <italic>Socs44A </italic>misexpression phenotype (Fig. <xref ref-type="fig" rid="F5">5E</xref>). In contrast, concurrent misexpression of <italic>Socs44A </italic>and <italic>argos </italic>had antagonistic effects. Misexpression of two copies of an <italic>argos </italic>transgene under the <italic>engrailed-GAL4 </italic>driver resulted in wings lacking the 4<sup>th </sup>lateral vein (L4) as well as both cross-veins (Fig. <xref ref-type="fig" rid="F5">5H</xref>). Concurrent misexpression of a single copy of the <italic>Socs44A </italic>transgene in this background was able to rescue this phenotype, restoring the posterior crossvein and both the most proximal and distal portions of L4 (Fig. <xref ref-type="fig" rid="F5">5I</xref>). The resulting wing phenotype mimicked that seen when only a single copy of <italic>argos </italic>was used in the misexpression assay (Fig. <xref ref-type="fig" rid="F5">5J</xref>) or what is seen in heteroallelic <italic>Egfr </italic>mutants (Fig. <xref ref-type="fig" rid="F5">5G</xref>). Finally, concurrent misexpression of a single copy of the <italic>argos </italic>and <italic>Socs44A </italic>transgenes produced a nearly wildtype wing (Fig. <xref ref-type="fig" rid="F5">5K</xref>). These data indicate that <italic>Socs44A </italic>expression is able to suppress <italic>argos </italic>misexpression phenotypes in a dose-dependent manner. It should be noted that concurrent misexpression of UAS-GFP did not affect the UAS-argos phenotype (not shown), indicating that the suppression by UAS-Socs44A was not merely a consequence of titrating GAL4.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Socs44A increases activity of EGFR signaling. </bold>The ectopic wing vein phenotype of <italic>Socs44A </italic>misexpression (A) is rescued by reduction of <italic>Egfr </italic>(B), <italic>Sos </italic>(C) or <italic>Ras85D </italic>(D), positive effectors of EGFR signaling. In contrast, reduction of <italic>argos</italic>, a negative regulator of EGFR signaling, enhances the <italic>Socs44A </italic>misexpression phenotype (E). The <italic>argos </italic>allele combined with en-GAL have no effect on venation without the UAS-Socs44A transgene (F). Certain heteroallelic <italic>Egfr </italic>mutants possess a distinct wing vein phenotype, whereby the anterior crossvein and the central portion of L4 is missing (G, arrows). <italic>Engrailed</italic>-driven misexpression of <italic>argos </italic>has a similar phenotype (H and J). Concurrent misexpression of <italic>Socs44A </italic>antagonizes <italic>argos </italic>misexpression to restore near normal wing venation (I and K). The designation "2xUAS-argos" refers to presence of 2 total copies of the transgene in the genome.</p></caption><graphic xlink:href="1471-2121-5-38-5"/></fig><p>Although these misexpression data indicate that Socs44A can enhance EGFR signaling, they do not necessarily demonstrate that this is a normal function of Socs44A. To address whether this is an endogenous function of Socs44A, we assayed the influence of a deficiency that removes <italic>Socs44A </italic>in the <italic>argos </italic>misexpression background. <italic>Engrailed-GAL4 </italic>misexpression of <italic>argos </italic>produces a range of phenotypic classes in which parts or all of L4 and/or the posterior cross-vein are missing (Fig. <xref ref-type="fig" rid="F6">6A</xref>). Addition of a single copy of a deficiency that removes <italic>Socs44A </italic>shifted the distribution of phenotypes to the more severe classes (Fig. <xref ref-type="fig" rid="F6">6B</xref>). In contrast, addition of an overlapping deficiency that does not include the <italic>Socs44A </italic>locus did not show such a shift. While it cannot be unambiguously stated that this effect is due to loss of <italic>Socs44A </italic>specifically, these results are consistent with the misexpression analyses and suggest that <italic>Socs44A </italic>normally plays a role in enhancing EGFR signaling in the <italic>Drosophila </italic>wing.</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Socs44A deficiencies enhance <italic>argos </italic>misexpression phenotypes. </bold>(A) The <italic>engrailed-GAL4 </italic>driven misexpression of <italic>argos </italic>produces a range of phenotypes which were classified based on severity. The combination of en-GAL and <italic>Df(2)CA53 </italic>had no effect on venation. (B) In flies that were also heterozygous for <italic>Df(2)CA53</italic>, which removes the <italic>Socs44A </italic>locus, the distribution of phenotypes was significantly shifted to more severe classes as compared to animals heterozygous for <italic>Df(2)Drl</italic><sup><italic>rv18</italic></sup>, an overlapping deficiency that does not remove <italic>Socs44A </italic>or for <italic>Sco</italic>, a chromosome wild-type for the 44A region.</p></caption><graphic xlink:href="1471-2121-5-38-6"/></fig></sec><sec><title>Socs36E and Socs44A have different effects on oogenesis</title><p>Evidence presented here and elsewhere indicates that Socs36E and Socs44A can downregulate JAK signaling in the wing [<xref ref-type="bibr" rid="B28">28</xref>]. However, the ability of specific mammalian SOCS to regulate JAK activity has been observed to differ, depending upon the tissue examined [<xref ref-type="bibr" rid="B43">43</xref>]. To determine whether there is a similar context specificity for the <italic>Drosophila </italic>SOCS, regulation was examined in another tissue in which JAK and EGFR functions have been well characterized. Both pathways are required for proper patterning of the follicular epithelium surrounding developing egg chambers during oogenesis [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B47">47</xref>]. One of the distinct cell populations requiring these pathways is the posterior terminal follicle cells [<xref ref-type="bibr" rid="B33">33</xref>]. These cells are molecularly identified by the expression of the ETS domain transcription factor, <italic>pointed </italic>[<xref ref-type="bibr" rid="B47">47</xref>-<xref ref-type="bibr" rid="B49">49</xref>]. In clones of cells that lack <italic>hop </italic>activity (Fig. <xref ref-type="fig" rid="F7">7C,7D,7E</xref>) or <italic>egfr </italic>activity (not shown), there is a loss of pnt-lacZ expression, indicating failure to specify the posterior terminal follicle cells.</p><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Socs36E and Socs44A have different activities during oogenesis. </bold>In wild-type ovaries (A, B), pnt-lacZ (red) is expressed in a gradient in the posterior terminal cells. Cells that lack <italic>hop </italic>activity (marked by a lack of green, see outline), also fail to express pnt-lacZ (C-E). Similarly, UAS-Socs36E misexpressed in clones (marked by presence of green, see outline), lack pnt-LacZ expression (F-H, see insets). In contrast, UAS-Socs44A misexpressed in clones (marked by presence of green, see outline), had no effect on pnt-LacZ expression (I-K). DAPI nuclear staining is shown in blue.</p></caption><graphic xlink:href="1471-2121-5-38-7"/></fig><p>To test whether Socs36E and Socs44A can downregulate JAK or EGFR activity during oogenesis, clones of cells misexpressing these genes in developing egg chambers were examined. In clones misexpressing <italic>Socs36E </italic>at high levels in posterior cells of the developing egg chamber, there was a dramatic loss of the pnt-LacZ marker (Fig. <xref ref-type="fig" rid="F7">7F,7G,7H</xref>). This loss was restricted to only those cells that misexpressed <italic>Socs36E </italic>and did not influence neighboring cells. These results indicate that JAK and/or EGFR signaling was attenuated by Socs36E activity. In contrast, for cells in which <italic>Socs44A </italic>was misexpressed in a similar fashion, there was no reduction of pnt-LacZ expression (Fig. <xref ref-type="fig" rid="F7">7I,7J,7K</xref>). We conclude that Socs44A is unable to attenuate JAK activity in the follicle cells. This ability of Socs44A to regulate JAK signaling in the wing, but not in the ovary, indicates that SOCS activity in invertebrates can also be context specific. Furthermore, the differential ability of the fly SOCS to attenuate JAK and EGFR signaling in the ovary demonstrates distinct functions for these two proteins.</p></sec></sec><sec><title>Discussion</title><p>The <italic>Drosophila </italic>genome encodes three homologues of the vertebrate SOCS. Each homologue contains the hallmark modular architecture, with a central SH2 domain followed by a carboxy-terminal SOCS domain. The genes are dispersed in the genome and are referred to by their cytological locations as <italic>Socs16D</italic>, <italic>Socs36E</italic>, and <italic>Socs44A</italic>. These fly SOCS genes are most similar to the vertebrate SOCS5, 6, and 7, none of which has been functionally characterized to date. Socs36E is the most similar in protein sequence to a vertebrate SOCS, SOCS5, but shares many characteristics with the extensively studied mammalian SOCS genes, SOCS1-3 and CIS. Each of these has been shown to be transcriptionally responsive to JAK pathway stimulation and act to downregulate JAK activity in a classical negative feedback loop [reviewed by [<xref ref-type="bibr" rid="B9">9</xref>]]. On the other hand, Socs44A is most similar to the less studied vertebrate genes, SOCS6 and 7. In this study, we demonstrated that Socs44A has properties that distinguish it from Socs36E and the canonical mammalian SOCS (compared in Table <xref ref-type="table" rid="T3">3</xref>). First, the expression of <italic>Socs44A </italic>was not dependent on JAK pathway activity. Nevertheless, Socs44A was able to downregulate the JAK cascade in some, but not all tissues. In addition to regulating JAK pathway activity, <italic>Socs44A </italic>genetically interacts with the EGFR/MAPK pathway, acting to enhance its activity.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Comparison of <italic>Drosophila </italic>SOCS.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center"><bold>Socs36E</bold></td><td align="center"><bold>Socs44A</bold></td></tr></thead><tbody><tr><td align="left"><bold>Expression-Embryogenesis</bold></td><td align="left"><bold>Matches </bold>known pattern of JAK activation, including pair-rule stripes, gut, and tracheal pits</td><td align="left"><bold>Distinct </bold>from JAK activation, with possible exception of trachea very late</td></tr><tr><td align="left"><bold>Expression- Oogenesis</bold></td><td align="left"><bold>Matches </bold>known pattern of JAK activation, with graded expression highest at anterior and posterior poles</td><td align="left"><bold>Distinct </bold>from JAK activation, with expression only in nurse cells</td></tr><tr><td align="left"><bold>Requirement for expression </bold></td><td align="left"><bold>Requires </bold>JAK signaling for embryonic expression</td><td align="left"><bold>Does not require </bold>JAK signaling for embryonic expression</td></tr><tr><td align="left"><bold>Inducibility</bold></td><td align="left"><bold>Inducible </bold>by JAK activity in embryos</td><td align="left"><bold>Not inducible </bold>by JAK activity in embryos</td></tr><tr><td align="left"><bold>Regulation of JAK activity</bold></td><td align="left"><bold>Can repress </bold>JAK signaling in wing and <bold>possibly </bold>in follicle cells of ovary</td><td align="left"><bold>Can repress </bold>JAK signaling in wing, but <bold>cannot </bold>in follicle cells</td></tr><tr><td align="left"><bold>Regulation of EGFR activity</bold></td><td align="left"><bold>Can repress </bold>EGFR signaling in wing and <bold>possibly </bold>in follicle cells of ovary</td><td align="left"><bold>Can enhance </bold>EGFR signaling in wing</td></tr></tbody></table><table-wrap-foot><p>The contrasting properties of Socs36E and Socs44A are summarized.</p></table-wrap-foot></table-wrap><sec><title>The <italic>Drosophila </italic>genome encodes three SOCS genes</title><p>Phylogenetically, SOCS fall into three general clades. The first includes the best studied vertebrate SOCS, CIS and SOCS1-3. Interestingly, there are no representatives of this group found in the fly genome. Vertebrate SOCS of the remaining two clades have yet to be fully characterized with regard to their physiological roles, as well as mechanistic roles in JAK/STAT signaling. <italic>Socs36E </italic>is most similar to the vertebrate SOCS of the second clade, containing SOCS4 and SOCS5. It shares similarity not only in the SH2 and SOCS domain, but also in the region upstream of the SH2 domain. Mutational analysis has shown that SOCS5 inhibits IL-6 [<xref ref-type="bibr" rid="B50">50</xref>], whereas nothing is known about the activity of SOCS4. <italic>Socs44A </italic>falls into the third clade occupied by vertebrate SOCS6 and SOCS7, as well as the only <italic>C. elegans </italic>homologue. SOCS6 has been shown to downregulate the insulin receptor [<xref ref-type="bibr" rid="B51">51</xref>,<xref ref-type="bibr" rid="B52">52</xref>]. Very little is known about SOCS7, other than its ability to interact with Nck, Ash, and PLC&#x003b3; [<xref ref-type="bibr" rid="B53">53</xref>]. Because of the relative lack of information about these latter two clades, study of the <italic>Drosophila </italic>SOCS may identify general properties of these homologues that span each clade.</p><p>Although mammalian genomes encode large families of specific JAK pathway components, <italic>Drosophila </italic>has only one characterized receptor, <italic>domeless</italic>, one Janus kinase, <italic>hop</italic>, and a single STAT, <italic>stat92E</italic>. Despite the simplicity of the transduction machinery for the JAK pathway, there are three SOCS genes in flies. Furthermore, there is only one <italic>Drosophila </italic>homologue of the PIAS negative regulatory family, <italic>zimp</italic>, and it is also capable of inhibiting JAK pathway activity [<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B55">55</xref>]. In an organism with few functionally redundant genes, why are there three <italic>Drosophila </italic>SOCS? Two possible explanations for the apparent abundance of SOCS are that the different <italic>Drosophila </italic>SOCS may be expressed differently or they may differently regulate signaling through pathways other than JAK. Indeed, we presented evidence for both of these distinctions for Socs36E and Socs44A.</p></sec><sec><title>Socs44A does not participate in an auto-regulatory negative feedback loop</title><p>It has been demonstrated that, like the classical vertebrate SOCS genes, <italic>Socs36E </italic>is transcriptionally responsive to JAK pathway activity [[<xref ref-type="bibr" rid="B29">29</xref>] and this work]. In both embryos and ovaries, the expression of <italic>Socs36E </italic>mirrors the known pattern of JAK activation and, indeed, altered JAK activation in the embryo elicits a transcriptional alteration in <italic>Socs36E</italic>. Unlike <italic>Socs36E</italic>, the expression of <italic>Socs44A </italic>did not match that of JAK induction. In the embryo, detectable <italic>Socs44A</italic> expression was absent until late stages of embryogenesis, when it was restricted to the developing trachea. JAK activation does occur in the tracheal pits and has been implicated in tracheal morphogenesis [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>], but <italic>Socs44A </italic>expression was lacking in the other tissues of the early embryo where JAK activation has been described. More telling was the finding that neither reduction nor expansion of JAK activation in the embryo had any effect on <italic>Socs44A </italic>expression. This disparity between <italic>Socs44A </italic>and <italic>Socs36E </italic>support the hypothesis that these genes are not redundant.</p><p>Despite the difference in expression of the two SOCS genes, both are able to downregulate JAK activity in some tissues. Misexpression of <italic>Socs36E </italic>is able to suppress JAK activity in the developing adult (imaginal) wing and thorax [<xref ref-type="bibr" rid="B28">28</xref>]. Similarly, misexpression of <italic>Socs44A </italic>reduced JAK activity in the imaginal wing, as illustrated by the enhancement of that phenotype by reduction of endogenous <italic>hop</italic>. Furthermore, misexpression of <italic>Socs44A </italic>rescued wing vein loss resulting from misexpression of <italic>hop</italic>. Perhaps most importantly, introduction of deficiencies that remove <italic>Socs44A </italic>rescued a <italic>hop </italic>wing vein phenotype. Taken together, these data strongly suggest that <italic>Socs44A</italic> downregulates JAK pathway activity during normal wing development. However, misexpression of <italic>Socs44A </italic>had no effect on expression of a marker for JAK pathway activity during oogenesis. This indicates that there is context specificity to SOCS action in <italic>Drosophila</italic>, a phenomenon that has been observed in the study of mammalian SOCS [<xref ref-type="bibr" rid="B43">43</xref>]. In contrast, misexpression of <italic>Socs36E </italic>was able to downregulate expression of the pnt-lacZ marker in follicle cells, although it cannot be distinguished whether this is due to reduction of signaling through JAK or EGFR. However, because <italic>Socs36E </italic>is expressed in the pattern of JAK activation in follicle cells, it is likely that it has a function in regulating JAK signaling in the ovary.</p></sec><sec><title>Socs44A upregulates EGFR/MAPK signaling</title><p>Another distinction we noted between the <italic>Drosophila </italic>SOCS was in their abilities to regulate signal transduction cascades in addition to JAK/STAT. Precedence for such additional roles for vertebrate SOCS include regulation of Tec, Vav, TCR, c-kit, and FAK mediated signaling [<xref ref-type="bibr" rid="B56">56</xref>-<xref ref-type="bibr" rid="B60">60</xref>]. It has been previously shown that Socs36E can suppress signaling not only through the JAK pathway, but also through the EGFR/MAPK pathway [<xref ref-type="bibr" rid="B28">28</xref>]. Socs44A was also able to regulate EGFR/MAPK signaling, but acted in the opposite manner. Socs44A was able to rescue misexpression of the EGFR negative regulator <italic>argos </italic>in a dose-dependent manner. Furthermore, mutations in EGFR pathway components rescued Socs44A misexpression phenotypes. Importantly, a reduction of endogenous <italic>Socs44A</italic> activity enhanced the <italic>argos </italic>phenotype. Taken together, these data suggest that a normal function for Socs44A is to enhance the EGFR pathway. A potential mechanism for this genetic interaction can be found in a recent report describing physical interaction between SOCS3 and the p120 RasGAP [<xref ref-type="bibr" rid="B61">61</xref>]. p120 RasGAP, a GTPase-Activating Protein, is an antagonist of MAPK signaling that is responsible for inactivating Ras. It does so by stimulating Ras GTP hydrolytic activity, leaving Ras in a GDP-bound, inactive configuration. Upon interaction with SOCS3, p120 RasGAP is unable to inactivate Ras, resulting in an upregulation of the EGFR/MAPK pathway. Perhaps Socs44A is acting in an analogous manner. Indeed, there are three candidate RasGAP genes in the fly genome. Biochemical analyses will be required to address this hypothesis.</p></sec></sec><sec><title>Conclusions</title><p>There are three <italic>Drosophila </italic>SOCS, all of which have greatest homology to the two classes of vertebrate SOCS that are least well characterized. One of these, Socs36E, is a member of the vertebrate SOCS4/5 class and has been previously characterized [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. It is similar to classical SOCS in that its expression is regulated by activity of the JAK pathway and that it functions to suppress JAK activity. Here we provided the initial characterization of Socs44A, a member of the vertebrate SOCS6/7 class. In contrast to <italic>Socs36E</italic>, activation of the JAK pathway was neither necessary nor sufficient for the expression of <italic>Socs44A</italic>. We conclude that Socs44A is unlike classical SOCS because it does not participate in a JAK pathway negative feedback loop. Still, Socs44A was capable of repressing JAK signaling, but that activity was limited to certain tissues. This context specificity is a feature that is shared with classical SOCS. Finally, Socs44A and Socs36E had opposite effects on EGFR/MAPK signaling. The enhancement of MAPK signaling that was seen for Socs44A is reminiscent of the influence of SOCS3 on this pathway, which is exerted through physical interaction of SOCS3 with p120 RasGAP. Perhaps a similar mechanism explains the enhancement of MAPK activity due to Socs44A. The differences observed here between Socs36E and Socs44A strongly suggest that they have distinct functions in the fly. Furthermore, the differences between Socs44A and the well studied class of canonical vertebrate SOCS may be representative of undiscovered distinctions amongst the three classes of vertebrate SOCS.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Comparison of SOCS sequences</title><p>Putative <italic>Drosophila </italic>SOCS genes were identified using a simple tBLASTn 2.0 query with a consensus sequence for the vertebrate SOCS domains [<xref ref-type="bibr" rid="B30">30</xref>] used to probe the complete genome contig sequences available from the BDGP. Identified homologies were compared with the predicted gene structures reported as "CG" sequences in the annotations of the genomic contigs. The translated sequences of the three putative SOCS gene genomic regions were scanned manually for possible alternative structures. The sequences surrounding the SOCS and SH2 domains were used to generate primers for the amplification of DNA corresponding to each putative gene. Amplification products were cloned and used to generate probes for the identification of cDNAs as described below. Phylogenetic comparison of SOCS proteins was performed using AlignX (VectorNTI 9.0), based on the ClustalW algorithm, to generate protein alignments and a neighbor-joining algorithm to create a phylogenetic tree.</p></sec><sec><title>Identification of cDNAs</title><p>A cDNA library constructed from RNA of 12&#x02013;24 hr old embryos [<xref ref-type="bibr" rid="B62">62</xref>] was screened using 800bp of genomic DNA derived from the 3' end of the <italic>Socs36E </italic>coding region, including the SOCS box and SH2 domain. Two independent clones (Genbank accessions AF435838 and AF435839) were recovered, with the former being structurally similar to an EST from the BDGP (clot #7147). The BDGP also recovered two cDNA clones representing <italic>socs44A </italic>which have been designated as clot #8463. We have determined the complete sequence of the longer clone, LP02169 (Genbank AF435923).</p></sec><sec><title>In situ hybridizations</title><p>In situ hybridizations to embryos were performed as previously described [<xref ref-type="bibr" rid="B32">32</xref>]. Digoxigenin labeled probes for <italic>Socs36E </italic>and <italic>Socs44A </italic>were generated from the 5' ends of the respective cDNAs and did not include the coding region for the conserved SH2 and SOCS domains. Germline clone mutants for the <italic>hop</italic><sup><italic>c111 </italic></sup>null allele were generated using the <italic>ovo</italic><sup><italic>D1 </italic></sup>dominant female sterile technique [<xref ref-type="bibr" rid="B34">34</xref>]. Embryos derived from mutant mothers were collected overnight and prepared for hybridizations as previously indicated. Embryos misexpressing <italic>upd </italic>in a specific pattern were generated by crossing females carrying a UAS-upd transgene with males heterozygous for paired-GAL4, which expresses GAL4 in the seven stripe pair-rule pattern of the <italic>paired </italic>gene. Progeny were collected and hybridized as above. Trachea in germline clone-derived <italic>hop</italic><sup><italic>c111 </italic></sup>embryos were visualized with the <italic>trh</italic><sup><italic>10512 </italic></sup>enhancer trap [<xref ref-type="bibr" rid="B63">63</xref>] using anti-&#x003b2;-gal antibody (Cortex Biochemical, at 1:1000) as previously described [<xref ref-type="bibr" rid="B26">26</xref>].</p></sec><sec><title>Misexpression studies</title><p>To express <italic>Socs36E </italic>and <italic>Socs44A </italic>under control of GAL4, the full-length cDNAs described above were cloned into the pUAST vector [<xref ref-type="bibr" rid="B64">64</xref>]. Germline transformations were performed [<xref ref-type="bibr" rid="B65">65</xref>] and transgenic lines established. For wing phenotypes, <italic>engrailed</italic>-GAL4 (e16E-GAL) was used to drive expression of the transgenes in the posterior compartment. Wings were dissected and mounted in Hoyer's medium [<xref ref-type="bibr" rid="B66">66</xref>] for photography.</p><p>Ovarian clones of the null allele, <italic>hop</italic><sup><italic>c111</italic></sup>, were generated by hsFLP mediated mitotic recombination as previously described [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. Misexpression clones of <italic>Socs36E </italic>and <italic>Socs44A </italic>were generated using a GAL4 flip-out cassette [<xref ref-type="bibr" rid="B67">67</xref>]. Genotypes of those animals were <italic>w [hsFLP]1</italic>; <italic>[Act5C&#x0003e;y&#x0003e;GAL4] [UAS-GFP.S65T]/ [UAS-socs36E]11.2 </italic>and <italic>w [hsFLP]1</italic>; <italic>[Act5C&#x0003e;y&#x0003e;GAL4] [UAS-GFP.S65T]/</italic>+; <italic>[UAS-socs44A]/ pnt-LacZ</italic>, respectively. For each, ovaries were fixed and stained with anti-&#x003b2; gal and anti-GFP as previously described [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B33">33</xref>].</p></sec><sec><title>Microscopy</title><p>All <italic>in situ </italic>hybridization and wing images were acquired using a Spot Camera (Diagnostic Instruments) on a Nikon E800 microscope using differential interference contrast (DIC). A Leica TCS-SP laser scanning confocal microscope was used to capture all fluorescence micrographs. All images were then exported to Adobe Photoshop for manipulation and annotation.</p></sec></sec><sec><title>Authors' contributions</title><p>JR performed experiments with Socs44A and participated in drafting the manuscript. GR performed most experiments with Socs36E. SH performed some experiments with Socs36E. RX performed immunofluorescence experiments in ovaries, except for Socs44A. DH conceived of the study, participated in its design and coordination, and participated in drafting the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We would like to thank the Berkeley <italic>Drosophila </italic>Genome Project and FlyBase for genome and EST sequences. We also thank T. Schupbach, M. Freeman, and the Bloomington Stock Center for fly strains. This work was supported by the NSF (IBN-0091535 to DAH), the University of Kentucky Biology Graduate Program (JSR), and a University of Kentucky Women's Fellowship (GR).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Shea</surname><given-names>JJ</given-names></name><name><surname>Gadina</surname><given-names>M</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name></person-group><article-title>Cytokine signaling in 2002: new surprises in the Jak/Stat pathway</article-title><source>Cell</source><year>2002</year><volume>109 Suppl</volume><fpage>S121</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11983158</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00701-8</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Igaz</surname><given-names>P</given-names></name><name><surname>Toth</surname><given-names>S</given-names></name><name><surname>Falus</surname><given-names>A</given-names></name></person-group><article-title>Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice</article-title><source>Inflamm Res</source><year>2001</year><volume>50</volume><fpage>435</fpage><lpage>441</lpage><pub-id pub-id-type="pmid">11603847</pub-id><pub-id pub-id-type="doi">10.1007/s000110050735</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rawlings</surname><given-names>JS</given-names></name><name><surname>Rosler</surname><given-names>KM</given-names></name><name><surname>Harrison</surname><given-names>DA</given-names></name></person-group><article-title>The JAK/STAT signaling pathway</article-title><source>J Cell Sci</source><year>2004</year><volume>117</volume><fpage>1281</fpage><lpage>1283</lpage><pub-id pub-id-type="pmid">15020666</pub-id><pub-id pub-id-type="doi">10.1242/jcs.00963</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lacronique</surname><given-names>V</given-names></name><name><surname>Boureux</surname><given-names>A</given-names></name><name><surname>Valle</surname><given-names>VD</given-names></name><name><surname>Poirel</surname><given-names>H</given-names></name><name><surname>Quang</surname><given-names>CT</given-names></name><name><surname>Mauchauffe</surname><given-names>M</given-names></name><name><surname>Berthou</surname><given-names>C</given-names></name><name><surname>Lessard</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>R</given-names></name><name><surname>Ghysdael</surname><given-names>J</given-names></name><name><surname>Bernard</surname><given-names>OA</given-names></name></person-group><article-title>A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia</article-title><source>Science</source><year>1997</year><volume>278</volume><fpage>1309</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">9360930</pub-id><pub-id pub-id-type="doi">10.1126/science.278.5341.1309</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname><given-names>P</given-names></name><name><surname>Raynaud</surname><given-names>SD</given-names></name><name><surname>Cools</surname><given-names>J</given-names></name><name><surname>Wlodarska</surname><given-names>I</given-names></name><name><surname>Grosgeorge</surname><given-names>J</given-names></name><name><surname>Philip</surname><given-names>P</given-names></name><name><surname>Monpoux</surname><given-names>F</given-names></name><name><surname>Van Rompaey</surname><given-names>L</given-names></name><name><surname>Baens</surname><given-names>M</given-names></name><name><surname>Van den Berghe</surname><given-names>H</given-names></name><name><surname>Marynen</surname><given-names>P</given-names></name></person-group><article-title>Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor- associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia</article-title><source>Blood</source><year>1997</year><volume>90</volume><fpage>2535</fpage><lpage>2540</lpage><pub-id pub-id-type="pmid">9326218</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>JM</given-names></name><name><surname>Beattie</surname><given-names>BK</given-names></name><name><surname>Squire</surname><given-names>JA</given-names></name><name><surname>Frank</surname><given-names>DA</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name></person-group><article-title>Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling</article-title><source>Blood</source><year>1999</year><volume>93</volume><fpage>4354</fpage><lpage>4364</lpage><pub-id pub-id-type="pmid">10361134</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowman</surname><given-names>T</given-names></name><name><surname>Garcia</surname><given-names>R</given-names></name><name><surname>Turkson</surname><given-names>J</given-names></name><name><surname>Jove</surname><given-names>R</given-names></name></person-group><article-title>STATs in oncogenesis</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>2474</fpage><lpage>2488</lpage><pub-id pub-id-type="pmid">10851046</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1203527</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coffer</surname><given-names>PJ</given-names></name><name><surname>Koenderman</surname><given-names>L</given-names></name><name><surname>de Groot</surname><given-names>RP</given-names></name></person-group><article-title>The role of STATs in myeloid differentiation and leukemia</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>2511</fpage><lpage>2522</lpage><pub-id pub-id-type="pmid">10851050</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1203479</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>WS</given-names></name></person-group><article-title>Suppressors of cytokine signalling (SOCS) in the immune system</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>410</fpage><lpage>416</lpage><pub-id pub-id-type="pmid">12093007</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zong</surname><given-names>C</given-names></name><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>August</surname><given-names>A</given-names></name><name><surname>Darnell</surname><given-names>JE</given-names></name><name><surname>Hanafusa</surname><given-names>H</given-names></name></person-group><article-title>Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase</article-title><source>EMBO J</source><year>1996</year><volume>15</volume><fpage>4515</fpage><lpage>4525</lpage><pub-id pub-id-type="pmid">8887543</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Tay</surname><given-names>A</given-names></name><name><surname>Guy</surname><given-names>GR</given-names></name><name><surname>Tan</surname><given-names>YH</given-names></name></person-group><article-title>Activation and association of Stat3 with Src in v-Src-transformed cell lines</article-title><source>Mol Cell Biol</source><year>1996</year><volume>16</volume><fpage>1595</fpage><lpage>1603</lpage><pub-id pub-id-type="pmid">8657134</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danial</surname><given-names>NN</given-names></name><name><surname>Pernis</surname><given-names>A</given-names></name><name><surname>Rothman</surname><given-names>PB</given-names></name></person-group><article-title>Jak-STAT signaling induced by the v-abl oncogene</article-title><source>Science</source><year>1995</year><volume>269</volume><fpage>1875</fpage><lpage>1877</lpage><pub-id pub-id-type="pmid">7569929</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CL</given-names></name><name><surname>Meyer</surname><given-names>DJ</given-names></name><name><surname>Campbell</surname><given-names>GS</given-names></name><name><surname>Larner</surname><given-names>AC</given-names></name><name><surname>Carter-Su</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Jove</surname><given-names>R</given-names></name></person-group><article-title>Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein</article-title><source>Science</source><year>1995</year><volume>269</volume><fpage>81</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">7541555</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kile</surname><given-names>BT</given-names></name><name><surname>Nicola</surname><given-names>NA</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name></person-group><article-title>Negative regulators of cytokine signaling</article-title><source>Int J Hematol</source><year>2001</year><volume>73</volume><fpage>292</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">11345194</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>CJ</given-names></name><name><surname>Hilton</surname><given-names>DJ</given-names></name></person-group><article-title>Negative regulation of cytokine signaling</article-title><source>J Leukoc Biol</source><year>2001</year><volume>70</volume><fpage>348</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">11527983</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>Warren S.</given-names></name><name><surname>Hilton</surname><given-names>Douglas J.</given-names></name></person-group><article-title>The Role of Suppressors of Cytokine Signaling (SOCS) Proteins in Regulation of the Immune Response</article-title><source>Annual Review of Immunology</source><year>2004</year><volume>22</volume><fpage>503</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">15032587</pub-id><pub-id pub-id-type="doi">10.1146/annurev.immunol.22.091003.090312</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamura</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Haque</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Kaelin</surname><given-names>W. G., Jr.</given-names></name><name><surname>Conaway</surname><given-names>RC</given-names></name><name><surname>Conaway</surname><given-names>JW</given-names></name></person-group><article-title>The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families</article-title><source>Genes Dev</source><year>1998</year><volume>12</volume><fpage>3872</fpage><lpage>3881</lpage><pub-id pub-id-type="pmid">9869640</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JG</given-names></name><name><surname>Farley</surname><given-names>A</given-names></name><name><surname>Nicholson</surname><given-names>SE</given-names></name><name><surname>Willson</surname><given-names>TA</given-names></name><name><surname>Zugaro</surname><given-names>LM</given-names></name><name><surname>Simpson</surname><given-names>RJ</given-names></name><name><surname>Moritz</surname><given-names>RL</given-names></name><name><surname>Cary</surname><given-names>D</given-names></name><name><surname>Richardson</surname><given-names>R</given-names></name><name><surname>Hausmann</surname><given-names>G</given-names></name><name><surname>Kile</surname><given-names>BJ</given-names></name><name><surname>Kent</surname><given-names>SB</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Hilton</surname><given-names>DJ</given-names></name><name><surname>Nicola</surname><given-names>NA</given-names></name><name><surname>Baca</surname><given-names>M</given-names></name></person-group><article-title>The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation</article-title><source>Proc Natl Acad Sci U S A</source><year>1999</year><volume>96</volume><fpage>2071</fpage><lpage>2076</lpage><pub-id pub-id-type="pmid">10051596</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.5.2071</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeidler</surname><given-names>MP</given-names></name><name><surname>Bach</surname><given-names>EA</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>The roles of the Drosophila JAK/STAT pathway</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>2598</fpage><lpage>2606</lpage><pub-id pub-id-type="pmid">10851058</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1203482</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barillas-Mury</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>YS</given-names></name><name><surname>Seeley</surname><given-names>D</given-names></name><name><surname>Kafatos</surname><given-names>FC</given-names></name></person-group><article-title>Anopheles gambiae Ag-STAT, a new insect member of the STAT family, is activated in response to bacterial infection</article-title><source>Embo J</source><year>1999</year><volume>18</volume><fpage>959</fpage><lpage>967</lpage><pub-id pub-id-type="pmid">10022838</pub-id><pub-id pub-id-type="doi">10.1093/emboj/18.4.959</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hombria</surname><given-names>JC</given-names></name><name><surname>Brown</surname><given-names>S</given-names></name></person-group><article-title>The fertile field of Drosophila Jak/STAT signalling</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>R569</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12194841</pub-id><pub-id pub-id-type="doi">10.1016/S0960-9822(02)01057-6</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DA</given-names></name><name><surname>Binari</surname><given-names>R</given-names></name><name><surname>Nahreini</surname><given-names>TS</given-names></name><name><surname>Gilman</surname><given-names>M</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects</article-title><source>EMBO J</source><year>1995</year><volume>14</volume><fpage>2857</fpage><lpage>2865</lpage><pub-id pub-id-type="pmid">7796812</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Hanratty</surname><given-names>WP</given-names></name><name><surname>Dearolf</surname><given-names>CR</given-names></name></person-group><article-title>An amino acid substitution in the Drosophila hopTum-l Jak kinase causes leukemia-like hematopoietic defects</article-title><source>EMBO J</source><year>1995</year><volume>14</volume><fpage>1412</fpage><lpage>1420</lpage><pub-id pub-id-type="pmid">7729418</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Rose</surname><given-names>P</given-names></name><name><surname>Barber</surname><given-names>D</given-names></name><name><surname>Hanratty</surname><given-names>WP</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>TM</given-names></name><name><surname>D'Andrea</surname><given-names>AD</given-names></name><name><surname>Dearolf</surname><given-names>CR</given-names></name></person-group><article-title>Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways.</article-title><source>Mol Cell Biol</source><year>1997</year><volume>17</volume><fpage>1562</fpage><lpage>1571</lpage><pub-id pub-id-type="pmid">9032284</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeidler</surname><given-names>MP</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Strutt</surname><given-names>DI</given-names></name></person-group><article-title>Polarity determination in the Drosophila eye: a novel role for unpaired and JAK/STAT signaling</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>1342</fpage><lpage>1353</lpage><pub-id pub-id-type="pmid">10346822</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGregor</surname><given-names>Jennifer R.</given-names></name><name><surname>Xi</surname><given-names>Rongwen</given-names></name><name><surname>Harrison</surname><given-names>Douglas A.</given-names></name></person-group><article-title>JAK signaling is somatically required for follicle cell differentiation in Drosophila</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>705</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">11830571</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>EA</given-names></name><name><surname>Vincent</surname><given-names>S</given-names></name><name><surname>Zeidler</surname><given-names>MP</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>A sensitized genetic screen to identify novel regulators and components of the Drosophila janus kinase/signal transducer and activator of transcription pathway</article-title><source>Genetics</source><year>2003</year><volume>165</volume><fpage>1149</fpage><lpage>1166</lpage><pub-id pub-id-type="pmid">14668372</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Callus</surname><given-names>BA</given-names></name><name><surname>Mathey-Prevot</surname><given-names>B</given-names></name></person-group><article-title>SOCS36E, a novel Drosophila SOCS protein, suppresses JAK/STAT and EGF-R signalling in the imaginal wing disc</article-title><source>Oncogene</source><year>2002</year><volume>21</volume><fpage>4812</fpage><lpage>4821</lpage><pub-id pub-id-type="pmid">12101419</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1205618</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karsten</surname><given-names>P</given-names></name><name><surname>Hader</surname><given-names>S</given-names></name><name><surname>Zeidler</surname><given-names>M</given-names></name></person-group><article-title>Cloning and expression of Drosophila SOCS36E and its potential regulation by the JAK/STAT pathway</article-title><source>Mech Dev</source><year>2002</year><volume>117</volume><fpage>343</fpage><pub-id pub-id-type="pmid">12204282</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(02)00216-2</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilton</surname><given-names>DJ</given-names></name><name><surname>Richardson</surname><given-names>RT</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name><name><surname>Viney</surname><given-names>EM</given-names></name><name><surname>Willson</surname><given-names>TA</given-names></name><name><surname>Sprigg</surname><given-names>NS</given-names></name><name><surname>Starr</surname><given-names>R</given-names></name><name><surname>Nicholson</surname><given-names>SE</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Nicola</surname><given-names>NA</given-names></name></person-group><article-title>Twenty proteins containing a C-terminal SOCS box form five structural classes</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>114</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">9419338</pub-id><pub-id pub-id-type="doi">10.1073/pnas.95.1.114</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>MD</given-names></name><name><surname>Celniker</surname><given-names>SE</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name><name><surname>Evans</surname><given-names>CA</given-names></name><name><surname>Gocayne</surname><given-names>JD</given-names></name><name><surname>Amanatides</surname><given-names>PG</given-names></name><name><surname>Scherer</surname><given-names>SE</given-names></name><name><surname>Li</surname><given-names>PW</given-names></name><name><surname>Hoskins</surname><given-names>RA</given-names></name><name><surname>Galle</surname><given-names>RF</given-names></name><name><surname>George</surname><given-names>RA</given-names></name><name><surname>Lewis</surname><given-names>SE</given-names></name><name><surname>Richards</surname><given-names>S</given-names></name><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Henderson</surname><given-names>SN</given-names></name><name><surname>Sutton</surname><given-names>GG</given-names></name><name><surname>Wortman</surname><given-names>JR</given-names></name><name><surname>Yandell</surname><given-names>MD</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>LX</given-names></name><name><surname>Brandon</surname><given-names>RC</given-names></name><name><surname>Rogers</surname><given-names>YH</given-names></name><name><surname>Blazej</surname><given-names>RG</given-names></name><name><surname>Champe</surname><given-names>M</given-names></name><name><surname>Pfeiffer</surname><given-names>BD</given-names></name><name><surname>Wan</surname><given-names>KH</given-names></name><name><surname>Doyle</surname><given-names>C</given-names></name><name><surname>Baxter</surname><given-names>EG</given-names></name><name><surname>Helt</surname><given-names>G</given-names></name><name><surname>Nelson</surname><given-names>CR</given-names></name><name><surname>Gabor Miklos</surname><given-names>GL</given-names></name><name><surname>Abril</surname><given-names>JF</given-names></name><name><surname>Agbayani</surname><given-names>A</given-names></name><name><surname>An</surname><given-names>HJ</given-names></name><name><surname>Andrews-Pfannkoch</surname><given-names>C</given-names></name><name><surname>Baldwin</surname><given-names>D</given-names></name><name><surname>Ballew</surname><given-names>RM</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Baxendale</surname><given-names>J</given-names></name><name><surname>Bayraktaroglu</surname><given-names>L</given-names></name><name><surname>Beasley</surname><given-names>EM</given-names></name><name><surname>Beeson</surname><given-names>KY</given-names></name><name><surname>Benos</surname><given-names>PV</given-names></name><name><surname>Berman</surname><given-names>BP</given-names></name><name><surname>Bhandari</surname><given-names>D</given-names></name><name><surname>Bolshakov</surname><given-names>S</given-names></name><name><surname>Borkova</surname><given-names>D</given-names></name><name><surname>Botchan</surname><given-names>MR</given-names></name><name><surname>Bouck</surname><given-names>J</given-names></name><name><surname>Brokstein</surname><given-names>P</given-names></name><name><surname>Brottier</surname><given-names>P</given-names></name><name><surname>Burtis</surname><given-names>KC</given-names></name><name><surname>Busam</surname><given-names>DA</given-names></name><name><surname>Butler</surname><given-names>H</given-names></name><name><surname>Cadieu</surname><given-names>E</given-names></name><name><surname>Center</surname><given-names>A</given-names></name><name><surname>Chandra</surname><given-names>I</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Cawley</surname><given-names>S</given-names></name><name><surname>Dahlke</surname><given-names>C</given-names></name><name><surname>Davenport</surname><given-names>LB</given-names></name><name><surname>Davies</surname><given-names>P</given-names></name><name><surname>de Pablos</surname><given-names>B</given-names></name><name><surname>Delcher</surname><given-names>A</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><name><surname>Mays</surname><given-names>AD</given-names></name><name><surname>Dew</surname><given-names>I</given-names></name><name><surname>Dietz</surname><given-names>SM</given-names></name><name><surname>Dodson</surname><given-names>K</given-names></name><name><surname>Doup</surname><given-names>LE</given-names></name><name><surname>Downes</surname><given-names>M</given-names></name><name><surname>Dugan-Rocha</surname><given-names>S</given-names></name><name><surname>Dunkov</surname><given-names>BC</given-names></name><name><surname>Dunn</surname><given-names>P</given-names></name><name><surname>Durbin</surname><given-names>KJ</given-names></name><name><surname>Evangelista</surname><given-names>CC</given-names></name><name><surname>Ferraz</surname><given-names>C</given-names></name><name><surname>Ferriera</surname><given-names>S</given-names></name><name><surname>Fleischmann</surname><given-names>W</given-names></name><name><surname>Fosler</surname><given-names>C</given-names></name><name><surname>Gabrielian</surname><given-names>AE</given-names></name><name><surname>Garg</surname><given-names>NS</given-names></name><name><surname>Gelbart</surname><given-names>WM</given-names></name><name><surname>Glasser</surname><given-names>K</given-names></name><name><surname>Glodek</surname><given-names>A</given-names></name><name><surname>Gong</surname><given-names>F</given-names></name><name><surname>Gorrell</surname><given-names>JH</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Guan</surname><given-names>P</given-names></name><name><surname>Harris</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><name><surname>Harvey</surname><given-names>D</given-names></name><name><surname>Heiman</surname><given-names>TJ</given-names></name><name><surname>Hernandez</surname><given-names>JR</given-names></name><name><surname>Houck</surname><given-names>J</given-names></name><name><surname>Hostin</surname><given-names>D</given-names></name><name><surname>Houston</surname><given-names>KA</given-names></name><name><surname>Howland</surname><given-names>TJ</given-names></name><name><surname>Wei</surname><given-names>MH</given-names></name><name><surname>Ibegwam</surname><given-names>C</given-names></name><name><surname>Jalali</surname><given-names>M</given-names></name><name><surname>Kalush</surname><given-names>F</given-names></name><name><surname>Karpen</surname><given-names>GH</given-names></name><name><surname>Ke</surname><given-names>Z</given-names></name><name><surname>Kennison</surname><given-names>JA</given-names></name><name><surname>Ketchum</surname><given-names>KA</given-names></name><name><surname>Kimmel</surname><given-names>BE</given-names></name><name><surname>Kodira</surname><given-names>CD</given-names></name><name><surname>Kraft</surname><given-names>C</given-names></name><name><surname>Kravitz</surname><given-names>S</given-names></name><name><surname>Kulp</surname><given-names>D</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Lasko</surname><given-names>P</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Levitsky</surname><given-names>AA</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Mattei</surname><given-names>B</given-names></name><name><surname>McIntosh</surname><given-names>TC</given-names></name><name><surname>McLeod</surname><given-names>MP</given-names></name><name><surname>McPherson</surname><given-names>D</given-names></name><name><surname>Merkulov</surname><given-names>G</given-names></name><name><surname>Milshina</surname><given-names>NV</given-names></name><name><surname>Mobarry</surname><given-names>C</given-names></name><name><surname>Morris</surname><given-names>J</given-names></name><name><surname>Moshrefi</surname><given-names>A</given-names></name><name><surname>Mount</surname><given-names>SM</given-names></name><name><surname>Moy</surname><given-names>M</given-names></name><name><surname>Murphy</surname><given-names>B</given-names></name><name><surname>Murphy</surname><given-names>L</given-names></name><name><surname>Muzny</surname><given-names>DM</given-names></name><name><surname>Nelson</surname><given-names>DL</given-names></name><name><surname>Nelson</surname><given-names>DR</given-names></name><name><surname>Nelson</surname><given-names>KA</given-names></name><name><surname>Nixon</surname><given-names>K</given-names></name><name><surname>Nusskern</surname><given-names>DR</given-names></name><name><surname>Pacleb</surname><given-names>JM</given-names></name><name><surname>Palazzolo</surname><given-names>M</given-names></name><name><surname>Pittman</surname><given-names>GS</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Pollard</surname><given-names>J</given-names></name><name><surname>Puri</surname><given-names>V</given-names></name><name><surname>Reese</surname><given-names>MG</given-names></name><name><surname>Reinert</surname><given-names>K</given-names></name><name><surname>Remington</surname><given-names>K</given-names></name><name><surname>Saunders</surname><given-names>RD</given-names></name><name><surname>Scheeler</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Shue</surname><given-names>BC</given-names></name><name><surname>Siden-Kiamos</surname><given-names>I</given-names></name><name><surname>Simpson</surname><given-names>M</given-names></name><name><surname>Skupski</surname><given-names>MP</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Spier</surname><given-names>E</given-names></name><name><surname>Spradling</surname><given-names>AC</given-names></name><name><surname>Stapleton</surname><given-names>M</given-names></name><name><surname>Strong</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>E</given-names></name><name><surname>Svirskas</surname><given-names>R</given-names></name><name><surname>Tector</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>R</given-names></name><name><surname>Venter</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>AH</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Wassarman</surname><given-names>DA</given-names></name><name><surname>Weinstock</surname><given-names>GM</given-names></name><name><surname>Weissenbach</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>SM</given-names></name><name><surname>Woodage</surname><given-names>T</given-names></name><name><surname>Worley</surname><given-names>KC</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yao</surname><given-names>QA</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Yeh</surname><given-names>RF</given-names></name><name><surname>Zaveri</surname><given-names>JS</given-names></name><name><surname>Zhan</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>XH</given-names></name><name><surname>Zhong</surname><given-names>FN</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>HO</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Venter</surname><given-names>JC</given-names></name></person-group><article-title>The genome sequence of Drosophila melanogaster</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>2185</fpage><lpage>2195</lpage><pub-id pub-id-type="pmid">10731132</pub-id><pub-id pub-id-type="doi">10.1126/science.287.5461.2185</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>DA</given-names></name><name><surname>McCoon</surname><given-names>PE</given-names></name><name><surname>Binari</surname><given-names>R</given-names></name><name><surname>Gilman</surname><given-names>M</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>Drosophila unpaired encodes a secreted protein that activates the JAK signaling pathway</article-title><source>Genes Dev</source><year>1998</year><volume>12</volume><fpage>3252</fpage><lpage>3263</lpage><pub-id pub-id-type="pmid">9784499</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>R</given-names></name><name><surname>McGregor</surname><given-names>JR</given-names></name><name><surname>Harrison</surname><given-names>DA</given-names></name></person-group><article-title>A gradient of JAK pathway activity patterns the anterior-posterior axis of the follicular epithelium</article-title><source>Dev Cell</source><year>2003</year><volume>4</volume><fpage>167</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">12586061</pub-id><pub-id pub-id-type="doi">10.1016/S1534-5807(02)00412-4</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>TB</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>Use of a yeast site-specific recombinase to produce female germline chimeras in Drosophila</article-title><source>Genetics</source><year>1992</year><volume>131</volume><fpage>643</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">1628809</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>N</given-names></name><name><surname>Hombria</surname><given-names>JC</given-names></name></person-group><article-title>Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless</article-title><source>Curr Biol</source><year>2001</year><volume>11</volume><fpage>1700</fpage><lpage>1705</lpage><pub-id pub-id-type="pmid">11696329</pub-id><pub-id pub-id-type="doi">10.1016/S0960-9822(01)00524-3</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>HW</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Marinissen</surname><given-names>MJ</given-names></name><name><surname>Gutkind</surname><given-names>JS</given-names></name><name><surname>Hou</surname><given-names>SX</given-names></name></person-group><article-title>mom identifies a receptor for the Drosophila JAK/STAT signal transduction pathway and encodes a protein distantly related to the mammalian cytokine receptor family</article-title><source>Genes Dev</source><year>2002</year><volume>16</volume><fpage>388</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">11825879</pub-id><pub-id pub-id-type="doi">10.1101/gad.955202</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Darnell</surname><given-names>J E, Jr</given-names></name><name><surname>Dearolf</surname><given-names>CR</given-names></name></person-group><article-title>A JAK-STAT pathway regulates wing vein formation in Drosophila</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>5842</fpage><lpage>5847</lpage><pub-id pub-id-type="pmid">8650180</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.12.5842</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinrich</surname><given-names>PC</given-names></name><name><surname>Behrmann</surname><given-names>I</given-names></name><name><surname>Haan</surname><given-names>S</given-names></name><name><surname>Hermanns</surname><given-names>HM</given-names></name><name><surname>Muller-Newen</surname><given-names>G</given-names></name><name><surname>Schaper</surname><given-names>F</given-names></name></person-group><article-title>Principles of interleukin (IL)-6-type cytokine signalling and its regulation</article-title><source>Biochem J</source><year>2003</year><volume>374</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">12773095</pub-id><pub-id pub-id-type="doi">10.1042/BJ20030407</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rane</surname><given-names>SG</given-names></name><name><surname>Reddy</surname><given-names>EP</given-names></name></person-group><article-title>Janus kinases: components of multiple signaling pathways</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>5662</fpage><lpage>5679</lpage><pub-id pub-id-type="pmid">11114747</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1203925</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shuai</surname><given-names>K</given-names></name></person-group><article-title>Modulation of STAT signaling by STAT-interacting proteins</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>2638</fpage><lpage>2644</lpage><pub-id pub-id-type="pmid">10851063</pub-id><pub-id pub-id-type="doi">10.1038/sj.onc.1203522</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shilo</surname><given-names>BZ</given-names></name></person-group><article-title>Signaling by the Drosophila epidermal growth factor receptor pathway during development</article-title><source>Exp Cell Res</source><year>2003</year><volume>284</volume><fpage>140</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">12648473</pub-id><pub-id pub-id-type="doi">10.1016/S0014-4827(02)00094-0</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Celis</surname><given-names>JF</given-names></name></person-group><article-title>Pattern formation in the Drosophila wing: The development of the veins</article-title><source>Bioessays</source><year>2003</year><volume>25</volume><fpage>443</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">12717815</pub-id><pub-id pub-id-type="doi">10.1002/bies.10258</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>JA</given-names></name><name><surname>O'Shea</surname><given-names>JJ</given-names></name></person-group><article-title>Matching SOCS with function</article-title><source>Nat Immunol</source><year>2003</year><volume>4</volume><fpage>507</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">12774070</pub-id><pub-id pub-id-type="doi">10.1038/ni0603-507</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beccari</surname><given-names>S</given-names></name><name><surname>Teixeira</surname><given-names>L</given-names></name><name><surname>Rorth</surname><given-names>P</given-names></name></person-group><article-title>The JAK/STAT pathway is required for border cell migration during Drosophila oogenesis</article-title><source>Mech Dev</source><year>2002</year><volume>111</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">11804783</pub-id><pub-id pub-id-type="doi">10.1016/S0925-4773(01)00615-3</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>DL</given-names></name><name><surname>Montell</surname><given-names>DJ</given-names></name></person-group><article-title>Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila</article-title><source>Cell</source><year>2001</year><volume>107</volume><fpage>831</fpage><lpage>841</lpage><pub-id pub-id-type="pmid">11779460</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00607-9</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Reyes</surname><given-names>A</given-names></name><name><surname>Elliott</surname><given-names>H</given-names></name><name><surname>St Johnston</surname><given-names>D</given-names></name></person-group><article-title>Polarization of both major body axes in Drosophila by gurken-torpedo signalling.</article-title><source>Nature</source><year>1995</year><volume>375</volume><fpage>654</fpage><lpage>658</lpage><pub-id pub-id-type="pmid">7791898</pub-id><pub-id pub-id-type="doi">10.1038/375654a0</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>S</given-names></name><name><surname>Neuman-Silberberg</surname><given-names>FS</given-names></name><name><surname>Barcelo</surname><given-names>G</given-names></name><name><surname>Schupbach</surname><given-names>T</given-names></name></person-group><article-title>cornichon and the EGF receptor signaling process are necessary for both anterior-posterior and dorsal-ventral pattern formation in Drosophila</article-title><source>Cell</source><year>1995</year><volume>81</volume><fpage>967</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">7540118</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(95)90016-0</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morimoto</surname><given-names>AM</given-names></name><name><surname>Jordan</surname><given-names>KC</given-names></name><name><surname>Tietze</surname><given-names>K</given-names></name><name><surname>Britton</surname><given-names>JS</given-names></name><name><surname>O'Neill</surname><given-names>EM</given-names></name><name><surname>Ruohola-Baker</surname><given-names>H</given-names></name></person-group><article-title>Pointed, an ETS domain transcription factor, negatively regulates the EGF receptor pathway in Drosophila oogenesis</article-title><source>Development</source><year>1996</year><volume>122</volume><fpage>3745</fpage><lpage>3754</lpage><pub-id pub-id-type="pmid">9012496</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Reyes</surname><given-names>A</given-names></name><name><surname>St Johnston</surname><given-names>D</given-names></name></person-group><article-title>Patterning of the follicle cell epithelium along the anterior-posterior axis during Drosophila oogenesis</article-title><source>Development</source><year>1998</year><volume>125</volume><fpage>2837</fpage><lpage>2846</lpage><pub-id pub-id-type="pmid">9655806</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>SE</given-names></name><name><surname>Willson</surname><given-names>TA</given-names></name><name><surname>Farley</surname><given-names>A</given-names></name><name><surname>Starr</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>JG</given-names></name><name><surname>Baca</surname><given-names>M</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Hilton</surname><given-names>DJ</given-names></name><name><surname>Nicola</surname><given-names>NA</given-names></name></person-group><article-title>Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction</article-title><source>Embo J</source><year>1999</year><volume>18</volume><fpage>375</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">9889194</pub-id><pub-id pub-id-type="doi">10.1093/emboj/18.2.375</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krebs</surname><given-names>DL</given-names></name><name><surname>Uren</surname><given-names>RT</given-names></name><name><surname>Metcalf</surname><given-names>D</given-names></name><name><surname>Rakar</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>JG</given-names></name><name><surname>Starr</surname><given-names>R</given-names></name><name><surname>De Souza</surname><given-names>DP</given-names></name><name><surname>Hanzinikolas</surname><given-names>K</given-names></name><name><surname>Eyles</surname><given-names>J</given-names></name><name><surname>Connolly</surname><given-names>LM</given-names></name><name><surname>Simpson</surname><given-names>RJ</given-names></name><name><surname>Nicola</surname><given-names>NA</given-names></name><name><surname>Nicholson</surname><given-names>SE</given-names></name><name><surname>Baca</surname><given-names>M</given-names></name><name><surname>Hilton</surname><given-names>DJ</given-names></name><name><surname>Alexander</surname><given-names>WS</given-names></name></person-group><article-title>SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>4567</fpage><lpage>4578</lpage><pub-id pub-id-type="pmid">12052866</pub-id><pub-id pub-id-type="doi">10.1128/MCB.22.13.4567-4578.2002</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mooney</surname><given-names>RA</given-names></name><name><surname>Senn</surname><given-names>J</given-names></name><name><surname>Cameron</surname><given-names>S</given-names></name><name><surname>Inamdar</surname><given-names>N</given-names></name><name><surname>Boivin</surname><given-names>LM</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><name><surname>Furlanetto</surname><given-names>RW</given-names></name></person-group><article-title>Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>25889</fpage><lpage>25893</lpage><pub-id pub-id-type="pmid">11342531</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M010579200</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matuoka</surname><given-names>K</given-names></name><name><surname>Miki</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Takenawa</surname><given-names>T</given-names></name></person-group><article-title>A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs</article-title><source>Biochem Biophys Res Commun</source><year>1997</year><volume>239</volume><fpage>488</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">9344857</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1997.7492</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohr</surname><given-names>SE</given-names></name><name><surname>Boswell</surname><given-names>RE</given-names></name></person-group><article-title>Zimp encodes a homologue of mouse Miz1 and PIAS3 and is an essential gene in Drosophila melanogaster</article-title><source>Gene</source><year>1999</year><volume>229</volume><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">10095110</pub-id><pub-id pub-id-type="doi">10.1016/S0378-1119(99)00033-5</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Betz</surname><given-names>A</given-names></name><name><surname>Lampen</surname><given-names>N</given-names></name><name><surname>Martinek</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>MW</given-names></name><name><surname>Darnell</surname><given-names>JE, Jr.</given-names></name></person-group><article-title>A Drosophila PIAS homologue negatively regulates stat92E</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>9563</fpage><lpage>9568</lpage><pub-id pub-id-type="pmid">11504941</pub-id><pub-id pub-id-type="doi">10.1073/pnas.171302098</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Sepulveda</surname><given-names>P</given-names></name><name><surname>Ilangumaran</surname><given-names>S</given-names></name><name><surname>Rottapel</surname><given-names>R</given-names></name></person-group><article-title>Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>14005</fpage><lpage>14008</lpage><pub-id pub-id-type="pmid">10747851</pub-id><pub-id pub-id-type="doi">10.1074/jbc.C000106200</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohya</surname><given-names>K</given-names></name><name><surname>Kajigaya</surname><given-names>S</given-names></name><name><surname>Yamashita</surname><given-names>Y</given-names></name><name><surname>Miyazato</surname><given-names>A</given-names></name><name><surname>Hatake</surname><given-names>K</given-names></name><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>U</given-names></name><name><surname>Shimada</surname><given-names>K</given-names></name><name><surname>Ozawa</surname><given-names>K</given-names></name><name><surname>Mano</surname><given-names>H</given-names></name></person-group><article-title>SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>27178</fpage><lpage>27182</lpage><pub-id pub-id-type="pmid">9341160</pub-id><pub-id pub-id-type="doi">10.1074/jbc.272.43.27178</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pircher</surname><given-names>TJ</given-names></name><name><surname>Geiger</surname><given-names>JN</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>CP</given-names></name><name><surname>Gaines</surname><given-names>P</given-names></name><name><surname>Wojchowski</surname><given-names>DM</given-names></name></person-group><article-title>Integrative signaling by minimal erythropoietin receptor forms and c-Kit</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>8995</fpage><lpage>9002</lpage><pub-id pub-id-type="pmid">11124255</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M007473200</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>E</given-names></name><name><surname>Cote</surname><given-names>JF</given-names></name><name><surname>Vuori</surname><given-names>K</given-names></name></person-group><article-title>Negative regulation of FAK signaling by SOCS proteins</article-title><source>Embo J</source><year>2003</year><volume>22</volume><fpage>5036</fpage><lpage>5046</lpage><pub-id pub-id-type="pmid">14517242</pub-id><pub-id pub-id-type="doi">10.1093/emboj/cdg503</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Sundstedt</surname><given-names>A</given-names></name><name><surname>Paulsson</surname><given-names>KM</given-names></name><name><surname>Anderson</surname><given-names>P</given-names></name><name><surname>Karlsson</surname><given-names>S</given-names></name><name><surname>Sjogren</surname><given-names>HO</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><article-title>Cytokine-induced Src homology 2 protein (CIS) promotes T cell receptor-mediated proliferation and prolongs survival of activated T cells</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>985</fpage><lpage>994</lpage><pub-id pub-id-type="pmid">10727460</pub-id><pub-id pub-id-type="doi">10.1084/jem.191.6.985</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cacalano</surname><given-names>NA</given-names></name><name><surname>Sanden</surname><given-names>D</given-names></name><name><surname>Johnston</surname><given-names>JA</given-names></name></person-group><article-title>Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras</article-title><source>Nat Cell Biol</source><year>2001</year><volume>3</volume><fpage>460</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">11331873</pub-id><pub-id pub-id-type="doi">10.1038/35074525</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>NH</given-names></name><name><surname>Kafatos</surname><given-names>FC</given-names></name></person-group><article-title>Functional cDNA libraries from Drosophila embryos</article-title><source>J Mol Biol</source><year>1988</year><volume>203</volume><fpage>425</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">3199441</pub-id><pub-id pub-id-type="doi">10.1016/0022-2836(88)90010-1</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isaac</surname><given-names>DD</given-names></name><name><surname>Andrew</surname><given-names>DJ</given-names></name></person-group><article-title>Tubulogenesis in Drosophila: a requirement for the trachealess gene product</article-title><source>Genes Dev</source><year>1996</year><volume>10</volume><fpage>103</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">8557189</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>AH</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name></person-group><article-title>Targeted gene expression as a means of altering cell fates and generating dominant phenotypes</article-title><source>Development</source><year>1993</year><volume>118</volume><fpage>401</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">8223268</pub-id></citation></ref><ref id="B65"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Spradling</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name><surname>D Roberts</surname></name></person-group><article-title>P element-mediated transformation</article-title><source>Drosophila: A practical approach</source><year>1986</year><publisher-name>Oxford, IRL Press</publisher-name><fpage>175</fpage><lpage>197</lpage></citation></ref><ref id="B66"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name></person-group><source>Drosophila: A Laboratory Manual</source><year>1989</year><publisher-name>Cold Spring Harbor, Cold Spring Harbor Laboratory Press</publisher-name><fpage>434</fpage></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Awano</surname><given-names>W</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Hiromi</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>D</given-names></name></person-group><article-title>The Drosophila mushroom body is a quadruple structure of clonal units each of which contains a virtually identical set of neurones and glial cells</article-title><source>Development</source><year>1997</year><volume>124</volume><fpage>761</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">9043058</pub-id></citation></ref></ref-list></back></article> 